Dahlia Biosciences Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$599K
- Investors
-
6
Dahlia Biosciences General Information
Description
Developer of RNA detection tools designed to allow precision medicine research. The company's tools use CRISPR-Cas9 technology that enables the detection of multiple DNA and RNA biomarkers directly in cells and tissues, enabling scientists to study and isolate cells at high resolution via sensitive, robust, and multiplexed RNA detection.
Contact Information
Website
www.dahliabio.comCorporate Office
- 953 Indiana Street
- San Francisco, CA 94017
- United States
Corporate Office
- 953 Indiana Street
- San Francisco, CA 94017
- United States
Dahlia Biosciences Timeline
Dahlia Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Grant | 30-Nov-2021 | $599K | Completed | Generating Revenue | ||
| 6. Grant | 01-Dec-2020 | Completed | Generating Revenue | |||
| 5. Grant | 03-Apr-2020 | Completed | Generating Revenue | |||
| 4. Seed Round | 07-Jun-2019 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 07-Nov-2017 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. University Spin-Out | 01-Jan-2017 | Completed | Startup |
Dahlia Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Dahlia Biosciences Executive Team (4)
| Name | Title | Board Seat |
|---|---|---|
| Un Kwon-Casado | Co-Founder, Chief Executive Officer and President | |
| Brad Taft | Chief Scientific Officer | |
| Samuel Sternberg Ph.D | Co-Founder & Scientific Advisor |
Dahlia Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Dahlia Biosciences Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Small Business Innovation Research and Small Business Technology Transfer Programs | Government | |||
| National Institutes of Health | Government | |||
| Avestria Ventures | Venture Capital | Minority | ||
| IndieBio | Accelerator/Incubator | Minority | ||
| SOSV | Venture Capital | Minority |
Dahlia Biosciences FAQs
-
When was Dahlia Biosciences founded?
Dahlia Biosciences was founded in 2017.
-
Who is the founder of Dahlia Biosciences?
Un Kwon-Casado, Samuel Sternberg Ph.D, and Michael Lin are the founders of Dahlia Biosciences.
-
Who is the CEO of Dahlia Biosciences?
Un Kwon-Casado is the CEO of Dahlia Biosciences.
-
Where is Dahlia Biosciences headquartered?
Dahlia Biosciences is headquartered in San Francisco, CA.
-
What is the size of Dahlia Biosciences?
Dahlia Biosciences has 7 total employees.
-
What industry is Dahlia Biosciences in?
Dahlia Biosciences’s primary industry is Biotechnology.
-
Is Dahlia Biosciences a private or public company?
Dahlia Biosciences is a Private company.
-
What is Dahlia Biosciences’s current revenue?
The current revenue for Dahlia Biosciences is .
-
How much funding has Dahlia Biosciences raised over time?
Dahlia Biosciences has raised $765K.
-
Who are Dahlia Biosciences’s investors?
Small Business Innovation Research and Small Business Technology Transfer Programs, National Institutes of Health, Avestria Ventures, IndieBio, and SOSV are 5 of 6 investors who have invested in Dahlia Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
